A detailed history of Israel Englander (Millennium Management LLC) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 739,819 shares of AXSM stock, worth $67.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
739,819
Previous 741,518 0.23%
Holding current value
$67.3 Million
Previous $59.2 Million 0.65%
% of portfolio
0.03%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$65.72 - $80.5 $111,658 - $136,769
-1,699 Reduced 0.23%
739,819 $59.6 Million
Q1 2024

May 15, 2024

SELL
$69.39 - $97.64 $11.7 Million - $16.4 Million
-168,447 Reduced 18.51%
741,518 $59.2 Million
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $10 Million - $14.6 Million
174,862 Added 23.79%
909,965 $72.4 Million
Q2 2023

Aug 14, 2023

SELL
$58.41 - $90.35 $17.8 Million - $27.5 Million
-304,264 Reduced 29.27%
735,103 $52.8 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $60.7 Million - $78 Million
1,039,367 New
1,039,367 $64.1 Million
Q3 2022

Nov 14, 2022

BUY
$36.06 - $69.85 $133,025 - $257,676
3,689 Added 1.06%
351,140 $15.7 Million
Q2 2022

Aug 15, 2022

BUY
$21.74 - $46.75 $7.17 Million - $15.4 Million
329,798 Added 1868.23%
347,451 $13.3 Million
Q1 2022

May 16, 2022

SELL
$23.7 - $41.39 $1.61 Million - $2.81 Million
-68,006 Reduced 79.39%
17,653 $731,000
Q4 2021

Feb 14, 2022

SELL
$30.7 - $43.36 $1.59 Million - $2.24 Million
-51,666 Reduced 37.62%
85,659 $3.24 Million
Q3 2021

Nov 15, 2021

SELL
$19.91 - $68.26 $1.58 Million - $5.43 Million
-79,514 Reduced 36.67%
137,325 $4.53 Million
Q2 2021

Aug 16, 2021

SELL
$50.63 - $73.5 $978,374 - $1.42 Million
-19,324 Reduced 8.18%
216,839 $14.6 Million
Q1 2021

May 17, 2021

BUY
$55.91 - $81.44 $4.88 Million - $7.1 Million
87,205 Added 58.54%
236,163 $13.4 Million
Q4 2020

Feb 16, 2021

BUY
$66.31 - $86.52 $3.09 Million - $4.04 Million
46,639 Added 45.58%
148,958 $12.1 Million
Q3 2020

Nov 16, 2020

SELL
$68.34 - $85.84 $3.75 Million - $4.72 Million
-54,935 Reduced 34.93%
102,319 $7.29 Million
Q2 2020

Aug 14, 2020

BUY
$49.87 - $98.69 $245,510 - $485,850
4,923 Added 3.23%
157,254 $12.9 Million
Q1 2020

May 14, 2020

SELL
$41.2 - $101.31 $14.5 Million - $35.7 Million
-352,407 Reduced 69.82%
152,331 $8.96 Million
Q4 2019

Feb 14, 2020

BUY
$16.71 - $106.24 $1.81 Million - $11.5 Million
108,438 Added 27.36%
504,738 $52.2 Million
Q3 2019

Nov 14, 2019

BUY
$20.24 - $29.16 $137,308 - $197,821
6,784 Added 1.74%
396,300 $8.02 Million
Q2 2019

Aug 15, 2019

SELL
$13.46 - $25.75 $9.04 Million - $17.3 Million
-671,829 Reduced 63.3%
389,516 $10 Million
Q2 2019

Aug 14, 2019

BUY
$13.46 - $25.75 $4 Million - $7.66 Million
297,371 Added 38.92%
1,061,345 $35.5 Million
Q1 2019

May 14, 2019

BUY
$2.63 - $16.34 $1.2 Million - $7.44 Million
455,172 Added 147.4%
763,974 $10.9 Million
Q4 2018

Feb 14, 2019

BUY
$2.0 - $4.15 $617,604 - $1.28 Million
308,802 New
308,802 $871,000
Q1 2018

May 15, 2018

SELL
$2.35 - $5.6 $295,879 - $705,073
-125,906 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$4.45 - $6.2 $196,476 - $273,742
-44,152 Reduced 25.96%
125,906 $705,000
Q3 2017

Nov 14, 2017

BUY
$4.65 - $6.1 $790,769 - $1.04 Million
170,058
170,058 $944,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.9B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.